Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Financing Arrangements

v3.20.4
Note 2 - Financing Arrangements
9 Months Ended
Dec. 27, 2020
Notes to Financial Statements  
Debt Disclosure [Text Block]
Note
2
– Financing Arrangements
 
Factoring Agreement
s:     
To reduce its exposure to credit losses, the Company assigns the majority of its trade accounts receivable to CIT pursuant to factoring agreements, which have expiration dates that are coterminous with that of the financing agreement described below. Under the terms of the factoring agreements, CIT remits customer payments to the Company as such payments are received by CIT.
 
CIT bears credit losses with respect to assigned accounts receivable from approved shipments, while the Company bears the responsibility for adjustments from customers related to returns, allowances, claims and discounts. CIT
may
at any time terminate or limit its approval of shipments to a particular customer. If such a termination or limitation occurs, then the Company either assumes (and
may
seek to mitigate) the credit risk for shipments to the customer after the date of such termination or limitation or discontinues shipments to the customer. Factoring fees, which are included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, amounted to
$79,000
and
$75,000
for the
three
-month periods ended
December 27, 2020
and
December 29, 2019,
respectively, and amounted to
$209,000
and
$188,000
for the
nine
-month periods ended
December 27, 2020
and
December 29, 2019,
respectively.
 
Credit Facility:
     
The Company's credit facility at
December 27, 2020
consisted of a revolving line of credit under a financing agreement with CIT of up to
$26.0
million, which includes a
$1.5
million sub-limit for letters of credit, bearing interest at the rate of prime minus
0.5%
or LIBOR plus
1.75%.
The financing agreement matures on
July 11, 2022
and is secured by a
first
lien on all assets of the Company. At
December 27, 2020,
the Company had elected to pay interest on balances owed under the revolving line of credit, if any, under the LIBOR option, which was
1.9%
as of
December 27, 2020.
The financing agreement also provides for the payment by CIT to the Company of interest at the rate of prime as of the beginning of the calendar month minus
2.0%,
which was
1.25%
as of
December 27, 2020,
on daily negative balances, if any, held at CIT.
 
As of
December 27, 2020,
there was
no
balance owed on the revolving line of credit, there was
no
letter of credit outstanding and
$26.0
million was available under the revolving line of credit based on the Company's eligible accounts receivable and inventory balances. As of
March 29, 2020,
there was a balance of
$2.6
million owed on the revolving line of credit, there was
no
letter of credit outstanding and
$20.1
million was available under the revolving line of credit based on the Company's eligible accounts receivable and inventory balances.
 
The financing agreement contains usual and customary covenants for agreements of that type, including limitations on other indebtedness, liens, transfers of assets, investments and acquisitions, merger or consolidation transactions, transactions with affiliates, and changes in or amendments to the organizational documents for the Company and its subsidiaries. The Company believes it was in compliance with these covenants as of
December 27, 2020.
 
Paycheck Protection Program
Loan
:
On
April 19, 2020,
the Company executed a Note (the “Note”) in connection with a loan (the “Loan”) made pursuant to the Paycheck Protection Program (the “PPP”), which is administered by the U.S. Small Business Administration (the “SBA”) under the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) and the Paycheck Protection Program Flexibility Act of
2020
(the “Flexibility Act”). The Note was entered into with CIT Bank, N.A. (the “Lender”) for the principal amount of
$1,963,800
and will accrue interest at
1.0%
per year. The Note will mature on
April 20, 2022,
at which time all remaining outstanding principal and accrued interest amounts under the Note will become due and payable.
 
As authorized by the provisions of the CARES Act, the Company
may
apply to the Lender for forgiveness of all or a portion of the Loan in an amount equal to the sum of certain allowable costs incurred by the Company during the
8
-week period beginning on
April 20, 2020.
The Flexibility Act extended this to a period of up to
24
weeks beginning on
April 20, 2020.
Such forgiveness will be determined, subject to limitations, based on the use of the proceeds of the Loan for payroll costs, mortgage interest, rent or utility costs.
 
The terms of the Note provided that beginning on
November 1, 2020,
the Company would be required to pay monthly installments of principal and interest in the amount necessary to fully amortize the Loan through the maturity date. However, the Flexibility Act provides that principal and interest payments will
not
be required to begin until subsequent to the date that the forgiveness amount is remitted to the Lender by the SBA, or the SBA otherwise notifies the Lender that the Loan is
not
eligible for forgiveness. The Note
may
be prepaid at any time prior to maturity without penalty.
 
On
October 15, 2020,
the Company submitted an application to the Lender for forgiveness of the full amount of the Loan. The Company has made a preliminary projection that the amount, if any, of the Loan that is determined to be forgiven will be remitted to the Lender by the SBA in
January 2021.
The Company has
not
presumed that any amount of such forgiveness of the Loan will be obtained, either in whole or in part, and has therefore made the assumption that monthly installments will commence in
February 2021
of principal and interest in the amount necessary to amortize the full amount of the Loan through the maturity date. The Company has accordingly classified principal payments in the aggregate amount of
$1.4
million as a current liability in the accompanying unaudited condensed consolidated balance sheet as of
December 27, 2020.
The remaining balance of the Loan outstanding as of
December 27, 2020
of
$524,000
has been presented as long-term debt in the accompanying unaudited condensed consolidated balance sheet, such amount being due and payable in monthly installments from
January 2022
through
April 2022.
 
The Note contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the Note. The occurrence of an event of default
may
result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, and/or filing suit and obtaining judgment against the Company. Additionally, the Note is subject to the terms and conditions applicable to loans administered by the SBA under the CARES Act and the Flexibility Act.